ATXN3 and Spinocerebellar ataxia type 3: We previously reported that a shRNA allele-specific lentiviral vector permitted selective silencing of mutant ataxin-3 in the striatum, while preserving wild-type ataxin-3, by targeting a C variant of the human ataxin-3 sequence that is present in 70% of the MJD patients [26].